Surveillance and Seroepidemiology

  • Alfred S. Evans


Surveillance has been described as the systematic collection of data pertaining to the occurrence of specific diseases, the analysis and interpretation of these data, and the dissemination of consolidated and processed information to contributors to the program and other interested persons. (57) The principles have been well set forth by Langmuir(41) for the United States Center for Disease Control (CDC) and by Raška(57) for the World Health Organization (WHO), and were a major focus of discussion of the Twenty-first World Health Assembly in 1968.(70) The techniques of surveillance have become a part of national and international programs of disease control. This chapter will discuss the background and elements of traditional surveillance, the concept and uses of serological epidemiology, and their application to the control of infectious diseases.


Communicable Disease Yellow Fever Immunization Program Infectious Mononucleosis Clinical Illness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Andrews, C. H., Laidlaw, P. P., and Smith, W., Influenza: Observations on the recovery of virus from man and on the antibody content of human sera, Br. J. Pathol. 16: 566–582 (1935).Google Scholar
  2. 2.
    Aycock, W. L., and Kramer, S. D., Immunity to poliomyelitis in normal individuals in urban and rural communities as indicated by the neutralization test, J. Prey. Med. 4: 189–200 (1930).Google Scholar
  3. 3.
    Baker, H., Infectious disease information and preparedness, Presented at meeting of the Society of Medical Consultants to the Armed Forces, U.S.A., Washington, D.C., 1973.Google Scholar
  4. 4.
    Balfour, H. H., Jr., Siem, R. A., Bauer, H., and Quie, P. G., California arbovirus (LaCrosse) infections. 1. Clinical and laboratory findings in 66 children with meningoencephalitis, Pediatrics 52: 680–691 (1973).PubMedGoogle Scholar
  5. 5.
    Bell, J. A., Huebner, R. J., Rosen, L., Rowe, W. P., Cole, R. M., Mastrot, F. M., Floyd, T. M., Chanock, R. M., and Shoedoff, R. A., Illness and microbial experiences of nursery children at Junior Village, Am. J. Hyg. 74: 267–292 (1961).Google Scholar
  6. 6.
    Blumberg, B. S., Alter, H. J., and Visnich, S., A “new” antigen in leukemia sera, J. Am. Med. Assoc. 191: 541–546 (1965).CrossRefGoogle Scholar
  7. 7.
    Blumberg, B. S., Gerstey, B. J. S., Hungerford, D. A., London, W. T., and Sutnik, A. I., A serum antigen (Australia antigen) in Down’s syndrome, leukemia, and hepatitis, Ann. Intern. Med. 66: 924–931 (1967).PubMedGoogle Scholar
  8. 8.
    Brown, H. W., The occurrence of neutralizing antibodies for human influenza virus in the sera of persons with various histories of influenza, Am. J. Hyg. 24: 361–380 (1936).Google Scholar
  9. 9.
    Ciongoli, A. K., Platz, P., Dupont, B., Svejgaard, A., Fog, T., and Jersild, C., Lack of antigen response to myxoviruses in multiple sclerosis, Lancet 2: 1147 (1973).PubMedGoogle Scholar
  10. 10.
    Cook, G. T., and Payne, A. M., Epidemiological control of infectious diseases, Br. Med. Bull. 7: 185–187 (1951).PubMedGoogle Scholar
  11. 11.
    Cooney, M. K., Hall, C. E., and Fox, J. P., The Seattle Virus Watch Program. I. Infection and illness experience of Virus Watch Families during a community-wide epidemic of echovirus 30 aseptic meningitis, Am. J. Public Health 60: 1456–1465 (1970).CrossRefGoogle Scholar
  12. 12.
    Cruickshank, R., Epidemiological surveillance of communicable diseases and development of public health laboratory facilities in the developing countries, in: Fourth International Congress on Global Impacts of Applied Microbiology, Sao Paulo, Brazil, abstracts (1973).Google Scholar
  13. 12a.
    De-Thé, G., Geser, A., Day, N., Inkei, P. M., Williams, E. H., Beri, D. P., Smith, P. G., Dean, A. G., Bornkamm, G. W., Feorino, P., and Henle, W., Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study, Nature (London) 274: 756–766 (1978).CrossRefGoogle Scholar
  14. 13.
    Dingle, J. H., Badger, G. F., and Jordan, W. S., Jr., Illness in the Home: A Study of 25,000 Illnesses in Group of Cleveland Families, Press of Western Reserve University, Cleveland, 1964.Google Scholar
  15. 14.
    Evans, A. S., Epidemiology and the public health laboratory, Am. J. Public Health 57: 1041–1052 (1967).CrossRefGoogle Scholar
  16. 15.
    Evans, A. S., Serological surveys: The role of the WHO Serum Reference Bank, WHO Chron. 21: 185–190 (1967).PubMedGoogle Scholar
  17. 16.
    Evans, A. S., Serological Techniques, in: Serological Epidemiology (J. R. Paul And C. White, eds.), pp. 42–54, Academic Press, New York, 1973.Google Scholar
  18. 17.
    Evans, A. S., Surveillance of mass vaccination program, in: Proceedings of the Fourth International Conference on Global Impacts of Applied Microbiology, Sao Paulo, Brazil (1973).Google Scholar
  19. 18.
    Evans, A. S., The history of infectious mononucleosis, Am. J. Med. Sci. 267: 189–195 (1974).PubMedCrossRefGoogle Scholar
  20. 19.
    Evans, A. S., New discoveries in infectious mononucleosis, Mod. Med. 42: 18–24 (1974).Google Scholar
  21. 19a.
    Evans, A. S., EB virus, infectious mononucleosis and cancer: The closing of the web, Yale J. Biol. Med. 47: 113–122 (1974).PubMedGoogle Scholar
  22. 19b.
    Evans, A. S., Serologic studies of acute respiratory infections in military personnel, Yale J. Biol. Med. 48: 201–209 (1975).PubMedGoogle Scholar
  23. 19c.
    Evans, A. S., Causation and disease: The Henle Koch postulates revisited, Yale J. Biol. Med. 49: 175–195 (1976).PubMedGoogle Scholar
  24. 19d.
    Evans, A. S., Causation and disease: A chronological journey, Am. J. Epidemiol. 108: 249–258 (1978).PubMedGoogle Scholar
  25. 19e.
    Evans, A. S., The need for serologic evaluation of immunization programs, Am. J. Epidemiol. 112: 725–731 (1980).PubMedGoogle Scholar
  26. 20.
    Evans, A. S., Carvalho, R. P. S., Frost, P., Jamra, M., and Pozzi, D. H. B., Epstein-Barr virus infections in Brazil. II. Hodgkin’s disease, J. Natl. Cancer Inst. 61: 19–26 (1978).PubMedGoogle Scholar
  27. 20a.
    Evans, A. S., Casals, J., Opton, E. M., Borman, E. K., Levine, L., and Cuadrado, R., A nationwide survey of Colombian military recruits, 1966. 1. Description of sample and antibody patterns with arboviruses, polioviruses, respiratory viruses, tetanus, and treponematosis, Am. J. Epidemiol. 90: 92–303 (1969).Google Scholar
  28. 21.
    Evans, A. S., Casals, J., Opton, E. M., Borman, E. K., Levine, L., and Cuadrado, R., A nationwide survey of Argentine military recruits, 1965–1966. I. Description of sample and antibody patterns with arboviruses, polioviruses, respiratory viruses, tetanus, and treponematosis, Am. J. Epidemiol. 93: 111–121 (1971).PubMedGoogle Scholar
  29. 21a.
    Evans, A. S., Cook, J. A., Kapikian, A. Z., Nankervis, G., Smith, A. L., and West, B., Serological Survey of St. Lucia, Int. J. Epidemiol. 8: 327–332, (1979).PubMedCrossRefGoogle Scholar
  30. 22.
    Evans, A. S., Cox, F., Nankervis, G., Opton, E., Shope, R., Wells, A. V., and West, B., A health and seroepidemiological survey of a community in Barbados, Int. J. Epidemiol. 3: 167–175 (1974).PubMedCrossRefGoogle Scholar
  31. 23.
    Evans, A. S., Niederman, J. C., and Mccollum, R. W., Seroepidemiologic studies of infectious mononucleosis with EB virus, N. Engl. J. Med. 279: 1121–1127 (1968).PubMedCrossRefGoogle Scholar
  32. 24.
    Evans, A. S., Niederman, J. C., and Sawyer, R. N., Prospective studies of a group of Yale University freshman. II. Occurrence of acute respiratory infections and rubella, J. Infect. Dis. 123: 271–278 (1971).PubMedCrossRefGoogle Scholar
  33. 25.
    Evans, A. S., Shepard, K. A., and Richards, V., ABO blood groups and viral diseases, Yale J. Biol. Med. 45: 81–92 (1972).PubMedGoogle Scholar
  34. 25a.
    Evans, A. S., Wells, A. V., Ramsey, F., Drabkin, P., and Plamer, K., Poliomyelitis, rubella, and dengue antibody survey in Barbados: A follow-up study, Int. J. Epidemiol. 8: 235–241 (1979).PubMedCrossRefGoogle Scholar
  35. 26.
    Falk, J., and Osoba, D., HL-A antigens and survival in Hodgkin’s disease, Lancet 2: 1118–1121 (1971).PubMedCrossRefGoogle Scholar
  36. 27.
    Florey, C., Duv., Cuadrado, R. R., Henderson, J. R., and De Goes, P., A nationwide serum survey of Brazilian military recruits, 1964: Method and sampling results, Am. J. Epidemiol. 86: 314–318 (1967).PubMedGoogle Scholar
  37. 28.
    Forbes, J. F., and Morris, P. J., Leucocyte antigens in Hodgkin’s disease, Lancet 2: 849–851 (1970).PubMedCrossRefGoogle Scholar
  38. 29.
    Foy, A. M., Cooney, M. K., Mcmahan, R., Bor, R., and Grayston, J. T., Single-dose monovalent A2/ Hong Kong influenza vaccine-Efficacy 14 months after immunization, J. Am. Med. Assoc. 217: 1067–1071 (1971).CrossRefGoogle Scholar
  39. 30.
    Fox, J., Elveback, L. R., Spigland, I., Frothingham, T. E., Stevens, D. A., and Huger, M., The Virus Watch Program: A continuing surveillance of viral infections in metropolitan New York families. 1. Overall plan, methods of collecting and handling information and a summary report of specimens collected and illnesses observed, Am. J. Epidemiol. 83: 389–412 (1966).Google Scholar
  40. 31.
    Francis, T. F., and Magill, T. P., The incidence of neutralizing antibody for human influenza virus in the serum of human individuals of different ages, J. Exp. Med. 63: 655–668 (1936).PubMedCrossRefGoogle Scholar
  41. 32.
    Gezer, A., Christensen, S., and Thorup, B., A mul-tipurpose serological survey in Kenya. 1. Survey methods and progress of field work, Bull. WHO 43: 521–537 (1970).Google Scholar
  42. 32a.
    Glezon, W. P., and Couch, R. B., Interpandemic influenza in the Houston area, 1974–1976, N. Engl. J. Med. 298: 587–592 (1978).CrossRefGoogle Scholar
  43. 33.
    Gold, E., Fevrier, A., Hatch, M. H., Hermann, K. L., Jones, W. L., Krugman, R. D., and Parkman, P.D., Immune status of urban children determined by antibody measurement, N. Engl. J. Med. 289: 231–234 (1973).PubMedCrossRefGoogle Scholar
  44. 34.
    Grumet, F. C., Coukell, A., Bodmer, J. G., Bodmer, W. F., and Mcdevitt, H. O., Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus: A possible genetic predisposition to disease, N. Engl. J. Med. 285: 193–196 (1971).PubMedCrossRefGoogle Scholar
  45. 35.
    Guthe, T., Ridet, J., Vorst, F., D’costa, J., and Grab, B., Methods for the surveillance of endemic treponematosis and seroimmunological investigations of “disappearing” disease, Bull. WHO 46: 1–14 (1972).PubMedGoogle Scholar
  46. 36.
    Henle, G., and Henle, W., Immunofluorescence in cells derived from Burkitt’s lymphoma, J. Bacteriol. 91: 1248–1256 (1966).PubMedGoogle Scholar
  47. 36a.
    Henle, G., Henle, W., and Diehl, V., Relationship of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis, Proc. Natl. Acad. Sci. U.S.A. 59: 94–101 (1968).PubMedCrossRefGoogle Scholar
  48. 37.
    Horstmann, D. M., Need for monitoring vaccinated populations for immunity levels, Prog. Med. Virol. 16: 215–240 (1973).PubMedGoogle Scholar
  49. 38.
    Horstmann, D. M., Liebhaber, H., Lebouvier, G. L., Rosenberg, D. A., and Halstead, S. G., Rubella: Reinfection of vaccinated and naturally immune persons exposed in an epidemic, N. Engl. J. Med. 283: 771–778 (1970).PubMedCrossRefGoogle Scholar
  50. 39.
    Jersild, C., Fog, T., Hansen, G. S., Thomsen, M., Svejgaard, A., and Dupont, B., Histocompatibility determinants in multiple sclerosis, with special reference to clinical course, Lancet 2: 1221–1225 (1973).PubMedCrossRefGoogle Scholar
  51. 40.
    Lamb, G. A., and Feldman, H. A., Rubella vaccine response and other viral antibodies in Syracuse children, Am. J. Dis. Child. 122: 117–121 (1971).PubMedGoogle Scholar
  52. 41.
    Langmuir, A. D., The surveillance of communicable diseases of national importance, N. Engl. J. Med. 268: 182–192 (1963).PubMedCrossRefGoogle Scholar
  53. 42.
    Mackay, I. R., and Morris, P. J., Association of autoimmune active chronic hepatitis with HL-A1,8, Lancet 2: 793–795 (1972).PubMedCrossRefGoogle Scholar
  54. 42a.
    Marier, R., The reporting of communicable diseases, Am. J. Epidemiol. 105: 587–590 (1977).PubMedGoogle Scholar
  55. 43.
    Mcdonald, J. D., and Zuckerman, A. J., ABO blood groups and acute respiratory disease, Br. Med. J 1: 89–90 (1962).CrossRefGoogle Scholar
  56. 44.
    Melnick, J. L., Burkhardt, M., Taber, L. T., and Erckman, P. N., Developing gap in immunity to poliomyelitis in an urban area, J. Am. Med. Assoc. 209: 1181–1185 (1969).CrossRefGoogle Scholar
  57. 45.
    Miller, D., Gabrielson, M. O., and Horstmann, D. M., Clinical virology and viral surveillance in a pediatriccc group practice: The use of double-seeded tissue cuiture tubes from primary virus isolation, Am. J. Epidemiol. 100: 516–517 (1974).Google Scholar
  58. 46.
    Monro, A. S., and Ullman, B. M., Acute respiratory illness in an American community, J. Am. Med. Assoc. 227: 164–169 (1974).CrossRefGoogle Scholar
  59. 47.
    National Disease and Therapeutic Index, Lea Associates, Ambler, Pennsylvania, 1969.Google Scholar
  60. 48.
    Niederman, J. C., Mccollum, R. W., Henle, G., and Henle, W., Infectious mononucleosis in relation to EB virus antibodies, J. Am. Med. Assoc. 203: 205–209 (1968).CrossRefGoogle Scholar
  61. 48a.
    Oldham, R. K., Dean, J. H., Cannon, G. B., Ortaldo, J. R., Dunston, G., Applebaum, F., Mccoy,J. L., Djen, J., and Herberman, R. B., Cryopreser vation of human lymphocytes function as measured by in vitro assays, Int. J. Cancer 18: 145–155 (1976).PubMedCrossRefGoogle Scholar
  62. 49.
    Oxford Universal Dictionary, Clarendon Press, Oxford, 1955.Google Scholar
  63. 50.
    Paul, J. R., Aims, purposes, and method of the World Health Organization Serum Banks, Yale J. Biol. Med. and control groups, Int. J. Cancer 36: 2–4 (1963).Google Scholar
  64. 51.
    Paul, J. R., The story to be learned from blood sam ples: Its value to the epidemiologist, J. Am. Med.Assoc. 175: 601–605 (1961).CrossRefGoogle Scholar
  65. 52.
    Paul, J. R., Serological Epidemiology in Clinical Epidemiology, rev. ed., University of Chicago Press, Chicago, 1966.Google Scholar
  66. 53.
    Paul, J. R., Niederman, J. C., Pearson, R. J. C., and Florey, C. Du V., A nationwide serum survey of United tates military recruits. 1. General consider ations, Am. J. Hyg. 80: 286–292 (1964).PubMedGoogle Scholar
  67. 54.
    Paul, J. R., and Riordan, J. T., Observations on ser ological epidemiology: Antibodies to the Lansing strain of poliomyelitis virus in sera from Alaskan Es-kimos, Am. J. Hyg. 52: 202–212 (1950).PubMedGoogle Scholar
  68. 55.
    Paul, J. R., and Trask, J. E., Neutralization test in poliomyelitis, comparative results with four strains of the virus, J. Exp. Med. 61: 447–464 (1935).PubMedCrossRefGoogle Scholar
  69. 56.
    Paul, J. R., and White, C. (eds.), Serological Epide- miology, Academic Press, New York, 1973.Google Scholar
  70. 56a.
    Purtilo, D. T., Bhawan, J., Hutt, L. M., Denikola, L., Szymanski, I., Yang, J. P. S., Boto, W., Maier, R., and Thorley-Lawson, D., Epstein-Barr virus in fections in the X-linked recessive lymphoproliferative syndrome, Lancet 1: 798–801 (1978).PubMedCrossRefGoogle Scholar
  71. 57.
    Raska, K., National and international surveillance of communicable diseases, WHO Chron. 20: 313–321 (1966).Google Scholar
  72. 58.
    Rolesgaard, E., Health regulations and international travel, WHO Chron. 28: 265–268 (1974).Google Scholar
  73. 58a.
    Rubin, R. J., and Gregg, M. B., A national influenza surveillance system: Methods and results, 1972–1974, Am. J. Epidemiol. 100: 516–517 (1974).Google Scholar
  74. 59.
    Russell, T. J., Schultes, L. M., and Kuban, D. J., Histocompatibility (HL-A) antigens associated with psoriasis, N. Engl. J. Med. 287: 738–740 (1972).PubMedCrossRefGoogle Scholar
  75. 60.
    Sawyer, R. N., Evans, A. S., Niederman, J. C., and Mccollum, R. W., Prospective studies of a group of Yale University freshman. 1. Occurrence of infectious mononucleosis, J. Infect. Dis. 123: 263–270 (1971).PubMedCrossRefGoogle Scholar
  76. 61.
    Schfosstein, L., Terasaki, P. I., Bluestone, R., and Pearson, C. M., High association of an HL-A antigen, W27, with anklylosing spondylitis, N. Engl. J. Med. 288: 704–706 (1973).CrossRefGoogle Scholar
  77. 62.
    Sever, J. L., Applications of a microtechnique to viral serologic investigations, J. Immunol. 88: 320–329 (1962).PubMedGoogle Scholar
  78. 63.
    Shope, R. E., Swine influenza. 1. Experimental trans-mission and pathology, J. Exp. Med. 54: 349–359 (1931).PubMedCrossRefGoogle Scholar
  79. 64.
    Simons, M. J., Wee, G. B., Day, N. E., Morris, P. J., Shanmugaratnam, K., and De The, G. B., Immuno-genetic aspects of nasopharyngeal carcinoma. 1. Differences in Hl-A antigen profiles between patients and control groups, Int. J. Cancer 13: 122–134 (1974).PubMedCrossRefGoogle Scholar
  80. 64a.
    Simons, M. J., Wee, G. B., Chan, S. H., Shanmu-Garatnam, K., Day, N. E., and De The, G. B., Immunogenetic aspects of nasopharyngeal carcinoma-(NPC). III. HL-A type as a genetic marker of NPC in: Second International Con-ference on Oncogenesis and Herpesviruses, Nuremberg, Germany, October 14–16, 1974.Google Scholar
  81. 64b.
    Simons, M. J., Chan, S. H., Wee, G. B., Shanmu-Garatnam, K., Day, N. E., and De-The, G. B., Prob-able identification of HL-A second-locus antigen as-sociated with a high risk of nasopharyngeal carcinoma, Lancet 1: 142–143 (1975).PubMedCrossRefGoogle Scholar
  82. 65.
    Soper, F. L., Penna, H., Cardosa, E., Serafim, J., Jr., Frosbisher, M., Jr., and Pinhiero, J., Yellow fever without Aedes aegypti: Study of a rural epidemic in the Valle do Chanaan, Espirito Santo, Brazil, Am. J. Hyg 18: 555–587 (1932).Google Scholar
  83. 66.
    Smith, W., Andrewes, C. H., and Laidlaw, P. O., A virus obtained from influenza patients, Lancet 2: 66–68 (1933).CrossRefGoogle Scholar
  84. 66a.
    Szmuness, W., Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association, Prog. Med. Virol. 24: 40–69 (1978).PubMedGoogle Scholar
  85. 67.
    Stokes, P. L., Asquith, P., Holmes, G. K. T., Mack-Intosh, P., and Cooke, W. T., Histocompatibility antigens associated with adult coeliac disease, Lancet 2: 162–164 (1974).Google Scholar
  86. 68.
    Thompson, W. H., and Evans, A. S., California virus encephalitis studies in Wisconsin, Am. J. Epidemiol. 81: 230–244 (1965).PubMedGoogle Scholar
  87. 69.
    Unterholer, V., and Zabriskie, J. B., Suppressed cellular immunity to measles antigen in multiple sclerosis patients, Lancet 2: 1147 (1973).Google Scholar
  88. 70.
    WHO, Proceedings of the Twenty-first World Health Assembly (1968).Google Scholar
  89. 71.
    WHO Tech. Rep. Ser., Immunological and Hematological Surveys, No. 181, Geneva (1959).Google Scholar
  90. 72.
    WHO Tech. Rep. Ser., MultipurposeSerological Survey and WHO Serum Reference Banks, No. 454, Geneva (1970).Google Scholar
  91. 73.
    Widelock, D., Klein, S., Peizer, L. R., and Simonovic, O., Laboratory analyses of 1957–1958 influenza outbreak (A/Japan) in New York City. I., Preliminary report on seroepidemiologic investigation and variant A/Japan isolate, J. Am. Med. Assoc. 167: 541–543 (1958).PubMedCrossRefGoogle Scholar
  92. 74.
    Williams, J. W., The value of the Wassermann reaction in obstetrics, based upon the study of 4547 consecutive cases, Johns Hopkins Hosp. Bull. 31: 335–342 (1920).Google Scholar
  93. 75.
    Zinkernagel, R. M., Major transplantation antigens in host responses to infection, Hosp. Pract. 13: 83–92 (1978).PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • Alfred S. Evans
    • 1
  1. 1.WHO Serum Reference Bank, Section of International Epidemiology, Department of Epidemiology and Public HealthYale University School of MedicineNew HavenUSA

Personalised recommendations